Listed companies
Biotech and healthcare: Taiwan listed companies
158 companies, highest median pay first.
| Company | Median pay, non-managerial | Women managers |
|---|---|---|
| PEI 4162 | NT$1,691,000 | 20.0% |
| Foresee 6576 | NT$1,435,000 | 23.3% |
| VISCO 6782 | NT$1,358,000 | 27.6% |
| LUMOSA 6535 | NT$1,238,000 | 75.0% |
| PEC 6446 | NT$1,230,000 | 44.9% |
| BRIM 6885 | NT$1,224,000 | 62.5% |
| Medeon 6499 | NT$1,210,000 | 60.0% |
| FRMSP 6838 | NT$1,158,000 | 28.6% |
| Handa Pharma 6620 | NT$1,110,000 | 50.0% |
| TTY 4105 | NT$1,102,000 | 52.3% |
| TSH 8432 | NT$1,083,000 | 50.0% |
| HNMC 7799 | NT$1,082,000 | 16.7% |
| OBI 4174 | NT$1,065,000 | 70.0% |
| SYNMOSA 4114 | NT$1,021,000 | 38.4% |
| NaviFUS 6872 | NT$1,016,000 | 20.0% |
| MEDIGEN 3176 | NT$1,014,000 | 75.0% |
| EirGenix 6589 | NT$1,014,000 | 39.4% |
| SH 6492 | NT$1,007,000 | 60.0% |
| PBI 6875 | NT$1,005,000 | 50.0% |
| OEP 4120 | NT$1,001,000 | 47.1% |
| Excelsior 6496 | NT$965,000 | 51.0% |
| UNIVERSAL 3218 | NT$946,000 | 49.0% |
| ENERGENESIS 6657 | NT$937,000 | 42.9% |
| FRMSL 4746 | NT$936,000 | 44.4% |
| onyx 6569 | NT$927,000 | 22.2% |
| TCI 8436 | NT$916,000 | 48.6% |
| Mycenax 4726 | NT$905,000 | 6.7% |
| HCI 1788 | NT$900,000 | 24.7% |
| TMB 4147 | NT$899,000 | 72.0% |
| DR.WU 6523 | NT$886,000 | 72.7% |
| SLS 3205 | NT$878,000 | 50.0% |
| S&S 4198 | NT$866,000 | 25.0% |
| GGA Corp. 4160 | NT$863,000 | 64.0% |
| CHBIO 6534 | NT$863,000 | 20.7% |
| UOC 4129 | NT$860,000 | 34.6% |
| Center Lab. 4123 | NT$848,000 | 13.7% |
| Vetnostrum 6936 | NT$848,000 | 54.0% |
| OP 4166 | NT$842,000 | 49.3% |
| SYN-TECH 1777 | NT$835,000 | 34.5% |
| LEVEL 3118 | NT$832,000 | 31.7% |
| Y.S.H. 3705 | NT$829,000 | 36.0% |
| INCX 6861 | NT$826,000 | 11.9% |
| Lotus Pharm 1795 | NT$825,000 | 41.7% |
| Cenra Inc. 3716 | NT$823,000 | 34.1% |
| MIC 6637 | NT$821,000 | 77.8% |
| DMT 4138 | NT$819,000 | 38.9% |
| SPT 1789 | NT$817,000 | 33.6% |
| BMTC 4116 | NT$817,000 | 12.0% |
| EXCELSIOR 4104 | NT$801,000 | 44.4% |
| PEGAVISION 6491 | NT$800,000 | 34.0% |
| Caliway 6919 | NT$798,000 | 55.0% |
| BioGend 6733 | NT$794,000 | 20.0% |
| WELLELL 4106 | NT$785,000 | 25.0% |
| BIONET CORP. 1784 | NT$784,000 | 77.8% |
| ONENESS BIOTECH 4743 | NT$775,000 | 62.1% |
| S.C.P.C 1720 | NT$772,000 | 43.5% |
| AmCad 4188 | NT$772,000 | 50.0% |
| SHAREHOPE 8403 | NT$772,000 | 60.0% |
| ARICH 4173 | NT$768,000 | 45.3% |
| NeoCore 4131 | NT$759,000 | 46.7% |
| MICROBIO 4128 | NT$757,000 | 73.3% |
| HCMED 6934 | NT$751,000 | 0.2% |
| DIVA Labs. 4153 | NT$750,000 | 15.0% |
| Sunmax 4728 | NT$745,000 | 34.3% |
| FORMOSA 5312 | NT$742,000 | 28.1% |
| GlycoNex Inc. 4168 | NT$739,000 | 75.0% |
| SCI 4119 | NT$729,000 | 28.4% |
| GKB 1707 | NT$728,000 | 44.4% |
| Alar 6785 | NT$727,000 | 71.4% |
| H&L 1781 | NT$721,000 | 21.0% |
| MiiS 6796 | NT$717,000 | 35.3% |
| EFAI 6841 | NT$715,000 | 3.6% |
| SVBI 1786 | NT$714,000 | 35.0% |
| VF 4771 | NT$714,000 | 25.0% |
| Delta Asia 6762 | NT$711,000 | 32.1% |
| Intech 6461 | NT$702,000 | 31.0% |
| PELL BMT 6949 | NT$690,000 | 60.0% |
| EASYWELL 1799 | NT$688,000 | 19.2% |
| BONRAYBIO 6955 | NT$687,000 | 50.0% |
| TCM 4169 | NT$685,000 | 48.0% |
| A Plus Biotech 6918 | NT$684,000 | 57.1% |
| PBF 1760 | NT$679,000 | 43.4% |
| MVC 6547 | NT$678,000 | 42.0% |
| JCP 4747 | NT$674,000 | 36.4% |
| Avita 4735 | NT$673,000 | 41.9% |
| UnicoCell 6794 | NT$671,000 | 71.4% |
| EBM 8409 | NT$670,000 | 3.5% |
| MBI 1783 | NT$668,000 | 38.2% |
| KIM FOREST 6645 | NT$667,000 | 55.0% |
| SLC 4167 | NT$661,000 | 23.8% |
| WeLeader 7713 | NT$660,000 | 37.5% |
| WELGENE 6661 | NT$657,000 | 43.8% |
| OK BIOTECH 4155 | NT$654,000 | 16.7% |
| SynCore 4192 | NT$650,000 | 33.3% |
| Maywufa 1731 | NT$649,000 | 50.0% |
| EPS Bio 4183 | NT$643,000 | 21.4% |
| BioLASCO 6662 | NT$642,000 | 13.3% |
| ROSSMAX 4121 | NT$640,000 | 46.1% |
| CHC 4164 | NT$640,000 | 39.2% |
| CCSB 1762 | NT$631,000 | 21.4% |
| St.Shine 1565 | NT$630,000 | 49.6% |
| ADIM 4142 | NT$628,000 | 28.0% |
| MIKOBEAUTE 6574 | NT$626,000 | 83.3% |
| PhytoHealth 4108 | NT$623,000 | 64.0% |
| CHI SHENG 4111 | NT$619,000 | 46.1% |
| SYNGEN 8279 | NT$618,000 | 29.8% |
| SHINY 6703 | NT$613,000 | 75.0% |
| SHANGYA 6130 | NT$610,000 | 33.3% |
| TAINET 4905 | NT$604,000 | 15.8% |
| SOFIVA 6615 | NT$603,000 | 52.6% |
| Ever Supreme 6712 | NT$597,000 | 25.0% |
| SINPHAR 1734 | NT$588,000 | 42.5% |
| Bora 6472 | NT$586,000 | 46.1% |
| Crystalvue 6527 | NT$584,000 | 23.5% |
| Wiltrom 6767 | NT$583,000 | 44.0% |
| INTAI 4163 | NT$582,000 | 31.3% |
| G&E 4911 | NT$581,000 | 50.0% |
| NORBEL 6844 | NT$578,000 | 40.0% |
| PAHSCO 4126 | NT$577,000 | 56.9% |
| NANG KUANG 1752 | NT$574,000 | 35.0% |
| Abnova 4133 | NT$570,000 | 52.0% |
| MedFirst 4175 | NT$570,000 | 1.4% |
| BIOPTIK 4161 | NT$562,000 | 60.0% |
| BIOTEQUE 4107 | NT$560,000 | 37.7% |
| TaiDoc 4736 | NT$556,000 | 48.6% |
| GenMont 3164 | NT$553,000 | 42.9% |
| Great Tree 6469 | NT$546,000 | 20.0% |
| ApexBio 1733 | NT$541,000 | 44.0% |
| YUNGZIP 4102 | NT$541,000 | 5.2% |
| LI KANG 6242 | NT$538,000 | 61.9% |
| ICARES 6612 | NT$520,000 | 45.8% |
| LAGIS 6730 | NT$518,000 | 13.2% |
| TLB 4127 | NT$511,000 | 27.3% |
| BIONIME 4737 | NT$508,000 | 25.6% |
| We Can 6929 | NT$506,000 | 80.8% |
| Polylite 1813 | NT$505,000 | 35.0% |
| Jia Jie Bio 4109 | NT$483,000 | 62.5% |
| CVC 4744 | NT$483,000 | 30.4% |
| Qing Song 6931 | NT$479,000 | 50.0% |
| TWBM 6649 | NT$386,000 | 14.3% |
| CHLITINA-KY 4137 | – | 71.1% |
| KY M.K. 4139 | – | 53.0% |
| ACBT 4148 | – | 46.4% |
| TAIGEN 4157 | – | 50.0% |
| StemCyte 4178 | – | 53.9% |
| JDS 4190 | – | 76.8% |
| Genomics 4195 | – | 33.3% |
| CMH 4745 | – | 55.6% |
| KL 6431 | – | 20.0% |
| Tanvex 6541 | – | 50.7% |
| PG 6550 | – | 57.1% |
| Applied BioCode 6598 | – | 36.4% |
| Gongwin 6617 | – | 8.3% |
| LLF-KY 6666 | – | 10.5% |
| APBio 6945 | – | 14.3% |
| HEXUN 6986 | – | 0.4% |
| aetherAI 7803 | – | 55.0% |
| Hanchor-KY 7827 | – | 20.0% |
Source: Financial Supervisory Commission and Taiwan Stock Exchange open data, ESG disclosures: human capital (2025, data.gov.tw, Government Open Data License v1). Listed companies must disclose the average and median pay of their full-time non-managerial staff each year. Compiled by The Hardest Market.